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Abstract
Aims Early exit from the workforce has been proposed to be one of the unfavorable consequences of diabetes. We examined 
whether early exit from the workforce differed between persons who were and were not diagnosed with diabetes during 
their work career.
Methods The cohort included 12,726 individuals of the Helsinki Birth Cohort Study, born between 1934 and 1944. Using 
data from nationwide registers, the cohort was followed up from early adulthood until they transitioned into retirement or 
died. Work-loss years were estimated using the restricted mean work years method.
Results During a follow-up of 382,328 person-years for men and 349 894 for women, 36.8% transitioned into old age pen-
sion and 63.2% exited workforce early. Among men, 40.5% of those with and 32.8% of those without diabetes transitioned 
into old age pension (p=0.003). The corresponding numbers for women were 48.6% and 40.4% (p = 0.013), respectively. 
Mean age at exit from the workforce was 60.1 (95% confidence interval [CI], 59.6 to 60.7) years among men with diabetes 
and 57.6 (95% CI, 57.2 to 58.0) years among men without diabetes (p = 0.016). Among women, corresponding ages were 
61.4 (95% CI, 60.8 to 61.9) years for those with diabetes and 59.5 (95% CI, 59.3 to 59.7) years for those without diabetes 
(p < 0.001). The difference in mean restricted work-loss years according to diabetes was 2.5 (95% CI 0.5 to 4.6) for men 
and 1.9 (95% CI 1.0 to 2.8) for women.
Conclusion Among individuals followed up throughout their work career, those with a diabetes diagnosis exited the work-
force approximately two years later compared to those without diabetes.
Keywords Diabetes mellitus · Diabetes medication · Early exit from workforce · Retirement · Disability pension · Life 
course · Epidemiology · Aging
Introduction
Governments’ long-term economic projections for public 
expenditure on pensions are strongly reliant on effective 
retirement ages and the assumption that people will exit the 
workforce at an older age in the future [1]. The employment 
rates of people aged 55–64 years have been rising during 
recent decades in the USA [2] and in the OECD countries, 
in the latter ones from 52 to 57% on average [3]. This is 
partly due to pension reforms in several countries. In 2014, 
the average pension age in OECD countries was 64.6 years 
for men and 63.1 years for women [3]. However, for example 
in Finland, in the year 2011 almost one-third of the working 
aged people had transitioned into disability pension already 
at an average age of 52 years [4]. Early exit from the labor 
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market is a challenge for the societies and has severe eco-
nomic implications.
Diabetes is globally one of the main non-communicable 
diseases with a prevalence of 422 million cases totaling 
8.5% of the adult population in 2014 [5]. As diabetes places 
a notable burden on the society [6], it can be viewed as a 
public health disease and an indicator of the general cardio-
metabolic health status of the population. Negative impacts 
of diabetes on direct costs such as healthcare services and 
indirect costs such as loss in productivity in, e.g., early exit 
from the workforce have been reported [7]. However, some 
inconsistent findings on the association between diabetes 
and premature retirement have been reported. In a 2-year 
follow-up in the US Health and Retirement Study, diabe-
tes was found to increase the risk of work cessation com-
pared to those with no diabetes among middle-aged men 
but not among women [8]. During an 18-year follow-up in 
the French GAZEL cohort, people with diabetes showed a 
trend toward an increased probability of transitioning from 
employment to work disability including disability pension 
compared to non-diabetics [9].
The association between diabetes and early retirement has 
so far not been studied from a life course perspective cov-
ering the entire work career. Using data from the Helsinki 
Birth Cohort Study, we studied whether early exit from the 
workforce differed between persons who were and were not 
diagnosed with diabetes during their work career.
Materials and methods
Study population
The Helsinki Birth Cohort Study comprises 13,345 individu-
als born in Helsinki, Finland, at Helsinki University Cen-
tral Hospital or Helsinki City Maternity Hospital between 
1934 and 1944 [10, 11]. The unique personal identity num-
ber assigned to all Finnish residents was used to link data 
from several national registers. The retirement decisions 
and records of diabetes date back to 1964 (cohort members 
were 20–30 years old), and they were followed up until the 
end of year 2013 (cohort members were 69–79 years old). 
Of the original cohort, we excluded those who had missing 
data on retirement (n = 112) and those who had migrated 
before retirement (n = 507). Thus, our study cohort included 
12,726 individuals who were followed up from early adult-
hood when they were available for work until they exited 
the workforce or died. The study was approved by the Eth-
ics Committee of Epidemiology and Public Health of the 
Hospital District of Helsinki and Uusimaa and that of the 
National Public Health Institute, Helsinki.
Early exit from the workforce
Information on date and type of pension was provided by 
the Finnish Centre for Pensions and the Finnish Social 
Insurance Institution and date of death by the Finnish Pop-
ulation Register Centre and was available for all cohort 
members. All Finnish residents who have lived in Finland 
for at least 3 years after they turned 16 years are covered 
by the pension system and are thus included in the pension 
registers. In Finland until 2005, the statutory retirement 
age was 63–65 years and from 2005 to 2016 63–68 years 
with the exception of certain professions that had younger 
retirement ages such as firemen and pilots. In the present 
study, the cohort members either transitioned into old age 
pension at the respective statutory retirement age or retired 
earlier and transitioned into disability, unemployment or 
part-time pension or died before retiring. Around 5% of 
the cohort carried on working past the age of 65 years 
(e.g., entrepreneurs working in the private sector). For 
these cohort members, there are no retirement data avail-
able in the pension registers during the follow-up. Among 
those who transitioned into old age pension, 90% retired 
at age 58–65 years. They did not have any work-loss years 
and were considered to have completed a normal work 
career. Early exit from the workforce in this study meant 
that the person transitioned into retirement before statu-
tory pension age due to disability, unemployment or part-
time pension or died before retiring. Disability pension 
is granted due to a medically confirmed illness when a 
person is unable to continue working even after periods of 
rehabilitation, re-education or assistance. For qualifying 
for unemployment pension, one needs to be unemployed, 
at least aged 60 years, had received unemployment benefits 
for at least 500 days and had accumulated employment 
pension for at least 5 years during the past 15 years. Part-
time pension meant that the person was partly working 
and partly retired. We calculated the work-loss years for 
each cohort member who retired early (due to disability, 
unemployment or part-time pension or death before any 
retirement) by deducting the date of retirement from the 
date when the cohort member turned 65 years.
Ascertainment of diabetes
Identification of diabetes cases was based on a record from 
any of the three sources: (1) record of any kind of diabetes 
medication purchase from the nationwide prescription reg-
ister of the Social Insurance Institution (Anatomical Ther-
apeutic Chemical [ATC] codes A10A, A10B and A10X) 
available from year 1995 onwards; (2) a record of entitle-
ment to reimbursement of medicine costs for diabetes from 
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the Social Insurance Institution (code 103) available from 
year 1964 onwards and (3) in- or outpatient care record 
with ICD-9 code 250 or ICD-10 code E10, E11, E12, E13 
or E14 from the national Care Register for Health Care 
available from year 1969 onwards. Each person was fol-
lowed up for a record of diabetes until they transitioned 
into retirement or died.
Socioeconomic status
Socioeconomic status in adulthood was ascertained using 
register data from Statistics Finland at 5-year intervals 
between the years 1970 and 2000. Highest occupational 
status was coded as upper middle class, lower middle class, 
self-employed and manual workers [12]. Highest educa-
tional attainment was ascertained using register data from 
Statistics Finland and coded as basic/primary or less, upper 
secondary, lower tertiary and upper tertiary.
Statistical analyses
Characteristics of the cohort members were compared 
according to diabetes status using t test for continuous vari-
ables and Chi-square test for discrete variables. The cumu-
lative percentage and differences in estimates of work-loss 
years across the work career according to diabetes status 
were estimated for men and women and illustrated by the 
Kaplan–Meier method. Differences between cumulative 
incidence curves were estimated using Cox proportional haz-
ards regression analyses with 5-knot restricted cubic splines 
adjusted for fixed covariate levels (birth year and socioeco-
nomic status in adulthood). Average age of exit from the 
workforce and the difference according to diabetes status 
was estimated using the restricted mean “survival” (work 
years) time (RMST) method [13]. All tests were performed 
two-tailed, the level of significance was set at p < 0.05 and 
analyses were carried out with STATA 14.1 (StataCorp LP, 
College Station, TX).
Results
The men in the cohort were followed up for 382,328 and the 
women for 349,894 person-years from early adulthood until 
they retired or died. Of the cohort members, 52.9% were 
men and the social class distribution of the cohort members 
was laborer for 40.4%, self-employed for 9.9% and low or 
high official for 49.6%. Of the cohort members, 36.8% had 
transitioned into old age pension and had no work-loss years. 
The rest (63.2%) retired early or died prematurely—28.8% 
transitioned into disability pension, 14.0% into unemploy-
ment pension, 12.8% into part-time pension and 7.6% had 
died before transitioning into any form of retirement. Of 
the 12,726 cohort members, 716 (469/6259, 7.5% men and 
247/5751, 4.3% women) had a record of diabetes before they 
retired or died without first transitioning into retirement. The 
mean age at first record of diabetes was 54.5 (SD 6.5) years 
for men and 54.7 (SD 7.0) years for women. Among women, 
childhood socioeconomic status was lower for those who 
had a record of diabetes (p = 0.02) and among men a similar 
trend was observed for socioeconomic status in adulthood 
(p = 0.06). There were no differences in educational attain-
ment according to diabetes status.
Table 1 presents retirement events and mean ages accord-
ing to diabetes status. Among men, 40.5% of those with and 
32.8% of those without diabetes transitioned into old age 
pension (p = 0.003). Among women, 48.6% of those with 
and 40.4% of those without diabetes transitioned into old 
Table 1  Retirement events/
deaths before retirement 
(number, proportion) and age in 
years (mean, SD) according to 
diabetes status
Retirement events Age at retirement
Diabetes No diabetes p Diabetes No diabetes p
Men
 Old age pension 190 (40.5) 2050 (32.8) 0.003 63.1 (1.9) 62.2 (3.4) < 0.001
 Premature pension
  Disability 128 (27.3) 1861 (29.7) 56.0 (5.5) 51.6 (8.5)
  Unemployment 54 (11.5) 892 (14.3) 60.2 (0.8) 60.1 (0.9)
  Part-time 61 (13.0) 769 (12.2) 58.4 (2.2) 58.3 (2.1)
 Death before retirement 36 (7.7) 687 (11.0) 51.3 (8.3) 47.4 (8.9)
Women
 Old age pension 120 (48.6) 2326 (40.4) 0.013 62.7 (2.1) 62.3 (2.4) < 0.001
 Premature pension
  Disability 49 (19.8) 1626 (28.3) 56.0 (8.1) 52.8 (7.6)
  Unemployment 41 (16.6) 796 (13.8) 60.4 (1.3) 60.1 (0.95)
  Part-time 26 (10.5) 769 (13.4) 58.4 (1.9) 58.2 (1.9)
 Death before retirement 11 (4.5) 234 (4.1) 51.5 (10.1) 49.9 (8.6)
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age pension (p = 0.013). Men and women with diabetes who 
transitioned into disability pension or died before retirement 
were older than those without diabetes (p < 0.001).
Figure 1 shows the distribution of work-loss years across 
the work career for all cohort members with and without 
diabetes. Of the subjects with diabetes 44.1% and of those 
without diabetes, 36.9% had no work-loss years, i.e., they 
transitioned into old age pension. The number of work-loss 
years varied between 1 and 44 years in the whole cohort. 
There were more persons with than without diabetes who 
had at most five work-loss years 30.9 versus 28.3%.
Figure 2 shows the risk of work-loss years with increasing 
age according to diabetes status for men and women who 
exited the workforce early and the differences in proportions 
of work-loss. For men the lines start to diverge already at age 
30 years according to diabetes status. A similar trend was 
observed among women, i.e., the lines started to diverge 
after age 40 years. The difference in work-loss years accord-
ing to diabetes status was biggest at age 55 years for men 
and 58 years for women. Among men, the mean retirement 
age was 60.1 (95% CI 59.6–60.7) years for those with and 
57.6 (95% CI 57.2–58.0) years for those without diabetes 
(p = 0.016, adjusted for birth year and adult socioeconomic 
status). Among women, the mean retirement age was 61.4 
(95% CI 60.8–61.9) years for those with and 59.5 (95% 
CI 59.3–59.7) years for those without diabetes (p < 0.001 
adjusted for birth year and adult socioeconomic status). The 
difference in the mean restricted work years according to 
diabetes status was 2.5 (95% CI 0.5–4.6) for men and 1.9 
(95% CI 1.0–2.8) for women in favor of those who had a 
record of diabetes during their work career.
Discussion
In this birth cohort followed up from early adulthood until 
retirement or death, we found that the men and women 
who had a diabetes diagnosis exited the workforce approx-
imately 2 years later compared to those without a record 
of diabetes. The difference in work-loss years between 
those with and without diabetes started to diverge already 
at age 30 years for men and at age 40 years for women 
and was higher for those with no record of diabetes. We 
investigated the main types of workforce exit including 
transitioning into old age, disability, unemployment and 
part-time pension as well as premature death.
In general, diabetes has been found to be related to loss 
in productivity in, e.g., early exit from the labor market 
[7]. However, studies have so far mostly reported cross-
sectional findings or have had relatively short follow-up 
times. Ervasti et al. [14] found in a Swedish register-based 
study that those who were diagnosed with diabetes had a 
higher number of annual work disability days around the 
time of diabetes diagnosis during the 7-year study period. 
The study outcome included both sickness absence and 
disability pension days, and it is not evident what the 
proportion of disability pension days was for those with 
incident diabetes during the 7-year follow-up. The study 
by Herquelot et al. [9] using data from the GAZEL cohort 
is one of the few studies which has a longer follow-up 
time. In the 18-year follow-up, the hazard of transitioning 
from employment to retirement or death for those with 
diabetes compared to those without diabetes was higher. 
However, in the study by Herquelot et al. [9] the hazard 
for transitioning into disability pension or being on sick 
leave for at least 1 year for those with diabetes compared 
to those without diabetes attenuated after adjustment for 
body mass index and was not statistically significant any 
longer. These findings together with our present findings 
provide some evidence that the association between dia-
betes and early workforce exit may not be as persistent as 
previously reported in studies based on shorter surveil-
lance time.
There are several potential factors that might explain 
our finding that those with diabetes had less work-loss 
years than those without diabetes. Although it has been 
shown that individuals who had a record of diabetes were 
more likely to be in worse health than those who did not 
have a record of diabetes, they might have received effec-
tive medical care for the disease and related conditions [5, 
15], thus potentially contributing to better overall health 
status and work ability [16]. Diabetes research has a long 
tradition in Finland. For example, the study findings of 
Yki-Järvinen et al. [17] in early 1990s on insulin therapy in 
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Fig. 1  Distribution of work-loss years during the work career for all 
cohort members according to diabetes status
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and the findings largely influenced the Finnish treatment 
strategies. Recent guidelines on diabetes care recommend 
simultaneous treatment for other closely related conditions 
such as dyslipidemia [18]. As part of standard treatment, 
diabetics receive lifestyle counseling which is likely to 
increase their awareness of the risks related to unhealthy 
living habits such as smoking which have been shown to 
be related to earlier exit from working life [19]. There is 
a growing body of evidence showing that interventions to 
prevent and control diabetes are successful and that they 
are cost-effective [20]. For example, a recent randomized 
trial with an 8-year intensified multifactorial intervention 
including behavioral and pharmacological approaches 
versus standard treatment among diabetics increased the 
median survival time and time free of cardiovascular dis-
ease by an average of 8 years [21]. Such findings, along 
with other recent positive results from trials on new diabe-
tes drugs [22], indicate that the impact of diabetes on work 
career performance might be effectively mitigated through 
multifactorial targeted interventions.
Age, years









































































Fig. 2  Left panel: the risk of work-loss increasing age according to 
diabetes status for men and women who existed workforce early. 
Right panel: The difference in the curves were derived from 5-knot 
(age centiles: 17, 33, 50, 67 and 83) restricted cubic spline regression 
models. The models were adjusted for birth year and adult socioeco-
nomic status. Gray area represents 95% confidence intervals
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The prevalence of diabetes was 5.6% in our cohort. This is 
in line with the 4.5% of Finnish residents aged 15–65 years 
who had a record of diabetes medication (ATC code A10) 
purchase in the prescription register of the Social Insurance 
Institution in the year 2016. However, under-diagnosis of 
diabetes is common and estimated to be around 20–50% 
[23]. It is likely that there are a number of individuals in the 
workforce suffering from undiagnosed and untreated diabe-
tes who perform worse than their healthy peers.
The strengths of our study include the long follow-up time 
covering the work career from early adulthood to retirement 
(or premature death). We were able to follow up the cohort 
until 95% of the cohort transitioned into retirement or died 
prematurely. Earlier evidence on the relationship between 
diabetes and retirement comes mainly from cross-sectional 
studies which might be biased in terms of representativeness 
of the study population [24]. Our data originate from the 
database of the nationwide social security system which has 
data on income security and social healthcare services, and 
include objective data and have been validated and found to 
be reliable [25]. Register data on pensions were available for 
all original cohort members (except for those who died or 
migrated before retirement), thus minimizing selection bias 
related to loss to follow-up. We had information on adult 
socioeconomic status from the national register for the entire 
cohort. The purpose of this paper was to investigate those 
with a diabetes diagnosis as an entity including other related 
comorbidities, which are known to be related to diabetes 
[14]; thus, we did not adjust for other chronic illnesses.
Some limitations of the study should be recognized. First, 
we focused on work-loss at the end of the work career. Dia-
betes may have resulted in sickness absence days during 
the work career, but we did not have these data available 
and cannot estimate the impact of diabetes on absence from 
work [26]. Second, specific information on type 1 and type 
2 diabetes was not available. Based on detailed assessments 
of the clinical sample of the HBCS data, about 5% of dia-
betes cases were type 1 and the rest type 2 diabetes. We do 
not have information on the exact date of diabetes diagno-
sis, but have used the first record of a diabetes medication 
reimbursement decision and/or purchase of medication and/
or hospital care due to diabetes as the onset day of diabe-
tes. Furthermore, we did not have data available on, e.g., 
work strain, work ability or lifestyle factors that might have 
explained some of the association analyzed here [27]. This 
is often the case in studies, so residual confounding might 
occur.
In conclusion, we found that persons who had a record 
of diabetes exited the workforce approximately two years 
later compared to those who did not have a record of dia-
betes. This study is to our knowledge the first that includes 
data across the entire work career for men and women. 
We also included premature death into our workforce exit 
events. Our finding is of major importance as the older 
population is encouraged to complete longer work careers 
and supports the importance of optimal medical and par-
ticularly diabetes treatment.
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